Skip to main content

Animations

MJFF Publications

6161 - 6170 of 6420 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2015
  • 2025
  • 2022
  • 2025
  • 2017
  • 2022
  • 2021
  • 2025
  • Summary Details
    OPEN
    Title: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2021.102569
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The Interaction between HLA‐DRB1 and Smoking in Parkinson's Disease Revisited
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29133
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.02.032
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Fox Insight: Most Bothersome Symptoms in Early‐Stage Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.14321
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.838674
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s40478-024-01913-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging study
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.438
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Human pericytes degrade diverse α-synuclein aggregates
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0277658
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Altered sphingolipid function in Alzheimer's disease; a gene regulatory network approach
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.001
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse model
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.70051
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.